According to ESPN’s Adam Schefter, the Los Angeles Chargers and Chicago Bears are on the rise complete a deal that would take Khalil Mack to the Charger in exchange for a second pick in 2022 and a sixth in 2023.
Since Mack began his four-year career in Chicago back in 2018, which included a trip to post-season, Mack hasn’t hit a double-digit total since then. In 2021, he played only seven games due to end-of-season foot surgery. More importantly, he has missed two of the past three seasons.
At one point Mack was mentioned in the same stratosphere as Aaron Donald of the Rams. However, three discsapplicationThe oil seasons in Chicago took some of Mack’s brilliance away and prompted him to rethink. He will be instrumental in the Chargers’ efforts to gain a foothold in a division that boasts some of the most dynamic midfielders in the league (Russell Wilson, Patrick Mahomes and Derek Carr, along with Chargers’ Justin Herbert ). Mack will be a boon to the Chargers front seven allowing for a charge of 138.9 yards per game, the third most in the NFL. He will have his hands full, but he will have help. Not only will Mack operate in the same LA market as Donald, but his third revival act will combine him with another game-changing defensive finish, Joey Bosa.
Bosa’s presence means that the Chargers have assembled one of the best passing duos in the NFL. That statement should stomp fear in the hearts of most quarterbacks, but especially against a particular enemy whose quarterback is one of the most-dismissed quarterbacks in the NFL. previous season.
The Las Vegas Raiders are the only ones who feel worse about trading Mack than the depressed Bears fan base. Next season, Derek Carr will have to face his former teammate twice. In 2014, he and Mack were the crown jewels of the 2014 Draft. Mack went on to win Defensive Player of the Year in 2017 before he was swapped for the Bears. Carr is the last player left from the 2014 Raiders, much less than their 2014 Draft. The Raiders were sitting patted as the chargers, Chiefs and Broncos raised their arms.
